Beginning of April, Maud Plantinga was granted for funding from the Wilhelmina Kinder Ziekenhuis (WKZ, Wilhemina Childrens Hospital) for her work on Dendritic Cell therapy. The next two years she will uncover the different DC subtypes and their functional specialization using single cell RNA sequence, to further optimize immunotherapeutic strategies with DC to treat (pediatric) patients.